Verici Dx Overview
- Year Founded
-
2020
- Status
-
Public
- Employees
-
22
- Stock Symbol
-
VRCI
Verici Dx General Information
Description
Verici Dx PLC is the development of prognostic and diagnostic tests for kidney transplant patients. It is a commercial stage diagnostics company, transforming the outcomes of kidney transplants through a complementary suite of proprietary, edge tests. These form a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. It has developed a suite of blood-based tests for kidney transplant patients. The group has one division being the development of prognostic and diagnostic tests for kidney transplant patients. The company's products are Tutivia, Clarava, Protega. The company's services are Next Generation Sequencing Services, Bioinformatics and Data Science Services.
Contact Information
Website
www.vericidx.comCorporate Office
- 393 Nichol Mill Lane
- Suite 200
- Franklin, TN 37067
- United States
Corporate Office
- 393 Nichol Mill Lane
- Suite 200
- Franklin, TN 37067
- United States
Verici Dx Timeline
Verici Dx Stock Performance
As of 18-Nov-2026, Verici Dx’s current market cap is $16.3M with 6.66B shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.3M | 6.66B | 10.1M |
Verici Dx Financials Summary
As of 30-Jun-2026, Verici Dx has a trailing 12-month revenue of $3.52M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 8,271 | 14,593 | 5,288 | 16,471 |
| Revenue | 3,522 | 3,664 | 3,339 | 1,013 |
| EBITDA | (7,315) | (6,404) | (5,405) | (8,038) |
| Net Income | (7,877) | (6,933) | (5,874) | (8,734) |
| Total Assets | 8,152 | 7,940 | 7,492 | 7,443 |
| Total Debt | 772 | 197 | 371 | 540 |
Verici Dx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Verici Dx Patents
Verici Dx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024372435-A1 | Pre-transplant blood based transcriptomic signatures for prediction of kidney transplant rejection | Pending | 30-Oct-2023 | ||
| EP-4802101-A1 | Pre-transplant blood based transcriptomic signatures for prediction of kidney transplant rejection | Pending | 30-Oct-2023 | ||
| WO-2025093575-A1 | Pre-transplant blood based transcriptomic signatures for prediction of kidney transplant rejection | Inactive | 30-Oct-2023 | ||
| AU-2023378357-A1 | Method and kits for a transcriptomic signature with empirically derived algorithm correlated to the presence of acute rejection on kidney biopsy in transplant recipient blood | Pending | 09-Nov-2022 | ||
| EP-4616002-A1 | Method and kits for a transcriptomic signature with empirically derived algorithm correlated to the presence of acute rejection on kidney biopsy in transplant recipient blood | Pending | 09-Nov-2022 | C12Q1/6883 |
Verici Dx Signals
Verici Dx Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Verici Dx ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Verici Dx FAQs
-
When was Verici Dx founded?
Verici Dx was founded in 2020.
-
Where is Verici Dx headquartered?
Verici Dx is headquartered in Franklin, TN.
-
What is the size of Verici Dx?
Verici Dx has 22 total employees.
-
What industry is Verici Dx in?
Verici Dx’s primary industry is Laboratory Services (Healthcare).
-
Is Verici Dx a private or public company?
Verici Dx is a Public company.
-
What is Verici Dx’s stock symbol?
The ticker symbol for Verici Dx is VRCI.
-
What is the current market cap of Verici Dx?
The current market capitalization of Verici Dx is $16.3M.
-
What is Verici Dx’s current revenue?
The trailing twelve month revenue for Verici Dx is $3.52M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process